ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $58,000 | -87.9% | 1,000 | -86.7% | 0.01% | -87.5% |
| Q1 2015 | $480,000 | -13.0% | 7,544 | -15.6% | 0.04% | -13.0% |
| Q4 2014 | $552,000 | +711.8% | 8,940 | +408.0% | 0.05% | +666.7% |
| Q3 2014 | $68,000 | -92.6% | 1,760 | -91.7% | 0.01% | -91.0% |
| Q1 2014 | $919,000 | +82.0% | 21,252 | +67.7% | 0.07% | +71.8% |
| Q4 2013 | $505,000 | -15.7% | 12,675 | -20.6% | 0.04% | -18.8% |
| Q3 2013 | $599,000 | – | 15,955 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |